KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Change in Receivables (2016 - 2025)

Jazz Pharmaceuticals has reported Change in Receivables over the past 16 years, most recently at $65.8 million for Q4 2025.

  • Quarterly results put Change in Receivables at $65.8 million for Q4 2025, up 7717.25% from a year ago — trailing twelve months through Dec 2025 was $106.3 million (up 403.33% YoY), and the annual figure for FY2025 was $106.3 million, up 403.33%.
  • Change in Receivables for Q4 2025 was $65.8 million at Jazz Pharmaceuticals, up from $51.0 million in the prior quarter.
  • Over the last five years, Change in Receivables for JAZZ hit a ceiling of $75.5 million in Q4 2023 and a floor of -$66.0 million in Q1 2025.
  • Median Change in Receivables over the past 5 years was $17.4 million (2021), compared with a mean of $18.1 million.
  • Peak annual rise in Change in Receivables hit 7717.25% in 2025, while the deepest fall reached 882.29% in 2025.
  • Jazz Pharmaceuticals' Change in Receivables stood at $64.8 million in 2021, then dropped by 28.58% to $46.3 million in 2022, then skyrocketed by 63.11% to $75.5 million in 2023, then tumbled by 101.14% to -$864000.0 in 2024, then soared by 7717.25% to $65.8 million in 2025.
  • The last three reported values for Change in Receivables were $65.8 million (Q4 2025), $51.0 million (Q3 2025), and $55.5 million (Q2 2025) per Business Quant data.